DK1653989T3 - Antibakteriel sammensætning især mod gramnegative bakterier og som omfatter et peptid og et fortrinsvist hydrofobt antibakterielt middel - Google Patents

Antibakteriel sammensætning især mod gramnegative bakterier og som omfatter et peptid og et fortrinsvist hydrofobt antibakterielt middel

Info

Publication number
DK1653989T3
DK1653989T3 DK04786310T DK04786310T DK1653989T3 DK 1653989 T3 DK1653989 T3 DK 1653989T3 DK 04786310 T DK04786310 T DK 04786310T DK 04786310 T DK04786310 T DK 04786310T DK 1653989 T3 DK1653989 T3 DK 1653989T3
Authority
DK
Denmark
Prior art keywords
peptide
amino acid
positively charged
negative bacteria
acid residues
Prior art date
Application number
DK04786310T
Other languages
Danish (da)
English (en)
Inventor
Valerie Arranz
Original Assignee
Cellectis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03292030A external-priority patent/EP1512696A1/en
Priority claimed from FR0309962A external-priority patent/FR2858772A1/fr
Application filed by Cellectis filed Critical Cellectis
Application granted granted Critical
Publication of DK1653989T3 publication Critical patent/DK1653989T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DK04786310T 2003-08-14 2004-08-13 Antibakteriel sammensætning især mod gramnegative bakterier og som omfatter et peptid og et fortrinsvist hydrofobt antibakterielt middel DK1653989T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03292030A EP1512696A1 (en) 2003-08-14 2003-08-14 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
FR0309962A FR2858772A1 (fr) 2003-08-14 2003-08-14 Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
PCT/FR2004/002142 WO2005018650A2 (fr) 2003-08-14 2004-08-13 Composition anti-bacterienne plus particulierement contre les bacteries gram negatif comprenent un peptide et un agent anti-bacterien avantageusement hydrophobe

Publications (1)

Publication Number Publication Date
DK1653989T3 true DK1653989T3 (da) 2009-11-23

Family

ID=34196165

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04786310T DK1653989T3 (da) 2003-08-14 2004-08-13 Antibakteriel sammensætning især mod gramnegative bakterier og som omfatter et peptid og et fortrinsvist hydrofobt antibakterielt middel

Country Status (12)

Country Link
US (2) US8293700B2 (ja)
EP (2) EP1653989B1 (ja)
JP (2) JP4755591B2 (ja)
AT (1) ATE533786T1 (ja)
AU (1) AU2004265159B2 (ja)
BR (1) BRPI0413521A (ja)
CA (2) CA2535745A1 (ja)
DE (1) DE602004022056D1 (ja)
DK (1) DK1653989T3 (ja)
ES (2) ES2330115T3 (ja)
IL (1) IL173362A0 (ja)
WO (2) WO2005016960A2 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
ES2330115T3 (es) * 2003-08-14 2009-12-04 Cellectis Composicion antibacteriana, mas particilarmente contra las bacterias gram-negativas, que comprende un peptido y un agente antibacteriano ventajosamente hidrofobo.
EP1797901A1 (en) 2005-12-16 2007-06-20 Diatos Cell penetrating peptide conjugates for delivering nucleic acids into cells
JP2009519033A (ja) * 2005-12-16 2009-05-14 ディアト 核酸を細胞に送達するための細胞貫通ペプチド結合体
EP1818395A1 (en) 2006-02-08 2007-08-15 Diatos Compositions and methods for treating lysosomal storage diseases
US20090312265A1 (en) * 2006-02-10 2009-12-17 Dermagen Ab Novel antimicrobial peptides and use thereof
EP1998809B1 (en) * 2006-03-30 2014-06-25 Drais Pharmaceuticals, Inc. Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
CN101516404B (zh) * 2006-03-30 2013-04-10 德莱斯医药公司 喜树碱-细胞渗透肽缀合物和含有其的药物组合物
EP1867661A1 (en) * 2006-06-12 2007-12-19 Diatos Compositions and methods for delivering anti-activated ras antibodies into cells
CA2791116A1 (en) 2010-02-26 2011-09-01 Olivier Danos Use of endonucleases for inserting transgenes into safe harbor loci
FR2968662B1 (fr) 2010-12-10 2013-11-22 Roussy Inst Gustave Nouveaux derives d'oxazaphosphorines pre-activees, utilisation et methode de preparation
WO2013039190A1 (ja) * 2011-09-15 2013-03-21 和歌山県 ペプチド含有ポリマー、及び繊維へのペプチド固定化方法
CN102665151B (zh) * 2012-04-24 2014-12-03 烽火通信科技股份有限公司 一种分组传送网中sdh业务dcc开销的处理方法及装置
JP6190534B2 (ja) 2013-08-22 2017-08-30 ソニー株式会社 水溶性蛍光染料又は有色染料及びその使用方法
CN113105559A (zh) 2013-12-12 2021-07-13 生命技术公司 增强转染的膜穿透性肽和组合物以及其使用方法
WO2016138461A1 (en) 2015-02-26 2016-09-01 Sony Corporation Water soluble fluorescent or colored dyes comprising conjugating groups
WO2017048092A1 (ko) * 2015-09-17 2017-03-23 서울대학교산학협력단 그람 음성균에 대한 항균 활성을 나타내는 끊어진 또는 꺾어진 나선 펩타이드 또는 펩타이드 유사체 및 이의 용도
CN109415411B (zh) 2015-09-17 2022-06-28 首尔大学校产学协力团 表现出抗革兰氏阴性菌的抗微生物活性的断开或折叠的螺旋肽或肽类似物及其用途
JP7068192B2 (ja) 2016-05-10 2022-05-16 ソニーグループ株式会社 ポリマー染料およびシクロデキストリンを含む組成物、ならびにその使用
EP3455238A1 (en) 2016-05-10 2019-03-20 Sony Corporation Ultra bright polymeric dyes with peptide backbones
US11685835B2 (en) 2016-05-11 2023-06-27 Sony Corporation Ultra bright dimeric or polymeric dyes
KR20200083605A (ko) 2017-11-16 2020-07-08 소니 주식회사 프로그램가능한 중합체성 약물
US11874280B2 (en) 2018-03-19 2024-01-16 Sony Group Corporation Use of divalent metals for enhancement of fluorescent signals
EP3768689A1 (en) 2018-03-21 2021-01-27 Sony Corporation Polymeric tandem dyes with linker groups
EP3861074A2 (en) 2019-09-26 2021-08-11 Sony Group Corporation Polymeric tandem dyes with linker groups

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4526888A (en) * 1983-04-29 1985-07-02 Bristol-Myers Company Nephrotoxicity inhibitors for aminoglycoside antibiotics
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US5254535A (en) 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
DK455789D0 (da) 1989-09-15 1989-09-15 Symbicom Ab Polypeptid
US5521291A (en) 1991-09-30 1996-05-28 Boehringer Ingelheim International, Gmbh Conjugates for introducing nucleic acid into higher eucaryotic cells
IL106998A0 (en) 1992-09-17 1993-12-28 Univ Florida Brain-enhanced delivery of neuroactive peptides by sequential metabolism
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
WO1994028921A1 (en) 1993-06-04 1994-12-22 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
AU3461095A (en) 1994-09-01 1996-03-22 Allied Medical Research Associates Compositions and methods for delivery of polypeptides
US5547929A (en) 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
AU3724495A (en) 1994-09-13 1996-03-29 Prizm Pharmaceuticals, Inc. Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
US5834430A (en) 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
FR2736642B1 (fr) 1995-07-10 1997-09-12 Pasteur Institut Immunovecteurs, notamment anticorps et fragments d'anticorps utilisables pour le transport intracellulaire et intranucleaire de principes biologiquement actifs notamment d'haptenes, de proteines et d'acides nucleiques
US6066485A (en) 1996-03-21 2000-05-23 New York University Growth factor inducible serine/threonine phosphatase fin13
US6503881B2 (en) 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6635623B1 (en) 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
US5967195A (en) 1997-08-01 1999-10-19 Weavexx Corporation Multi-layer forming fabric with stitching yarn pairs integrated into papermaking surface
FR2766826B1 (fr) 1997-08-04 2001-05-18 Pasteur Institut Vecteurs derives d'anticorps pour le transfert de substances dans les cellules
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
DE69837148T2 (de) 1997-12-23 2007-10-31 Alexion Pharmaceuticals, Inc., New Haven Chimäre proteine zur behandlung von diabetes
US6348185B1 (en) 1998-06-20 2002-02-19 Washington University School Of Medicine Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6855801B1 (en) 1999-02-02 2005-02-15 Thomas Jefferson University Peptides modulating activities of heparin other glycosaminoglycans or proteoglycans
CA2361612A1 (en) 1999-02-02 2000-08-10 Thomas Jefferson University Peptides modulating activities of heparin, other glycosaminoglycans or proteoglycans
JP4513145B2 (ja) * 1999-09-07 2010-07-28 ソニー株式会社 半導体装置の製造方法および研磨方法
FR2805821B1 (fr) * 2000-03-01 2004-01-16 Diatos Sequences d'acides amines facilitant la penetration d'une substance d'interet a l'interieur des cellules et/ou des noyaux cellulaires
US8003595B2 (en) 2000-03-01 2011-08-23 Cellectis Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
US20110131679A2 (en) 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US6835536B2 (en) 2001-08-21 2004-12-28 Micrologix Biotech Inc. Antimicrobial cationic peptides and formulations thereof
US7049286B2 (en) * 2001-08-30 2006-05-23 Diatos, S.A. Insulin conjugates and methods of use thereof
AU2003223923A1 (en) 2002-05-01 2003-11-17 Pantheco A/S Peptide nucleic acid conjugates with transporter peptides
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
JP2006504657A (ja) 2002-07-24 2006-02-09 ユニべルシテ・カトリック・ドゥ・ルベン アンスラサイクリン−ペプチドコンジュゲートの合成方法
ES2330115T3 (es) 2003-08-14 2009-12-04 Cellectis Composicion antibacteriana, mas particilarmente contra las bacterias gram-negativas, que comprende un peptido y un agente antibacteriano ventajosamente hidrofobo.
US20060281897A1 (en) 2003-08-22 2006-12-14 Andre Trouet Potentialization of the activation of high molecular weight prodrugs

Also Published As

Publication number Publication date
US20070042492A1 (en) 2007-02-22
IL173362A0 (en) 2006-06-11
ATE533786T1 (de) 2011-12-15
EP1654285B1 (en) 2011-11-16
EP1654285A2 (en) 2006-05-10
WO2005018650A3 (fr) 2005-06-16
JP2007529194A (ja) 2007-10-25
BRPI0413521A (pt) 2006-10-10
ES2378312T3 (es) 2012-04-11
WO2005018650A2 (fr) 2005-03-03
AU2004265159B2 (en) 2010-08-19
JP2007502262A (ja) 2007-02-08
JP4633055B2 (ja) 2011-02-16
US7544664B2 (en) 2009-06-09
ES2330115T3 (es) 2009-12-04
US8293700B2 (en) 2012-10-23
WO2005016960A2 (en) 2005-02-24
EP1653989B1 (fr) 2009-07-15
JP4755591B2 (ja) 2011-08-24
CA2535670A1 (en) 2005-02-24
CA2535745A1 (fr) 2005-03-03
US20070259813A1 (en) 2007-11-08
WO2005016960A3 (en) 2005-04-07
EP1653989A2 (fr) 2006-05-10
DE602004022056D1 (de) 2009-08-27
AU2004265159A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
DK1653989T3 (da) Antibakteriel sammensætning især mod gramnegative bakterier og som omfatter et peptid og et fortrinsvist hydrofobt antibakterielt middel
DE60235761D1 (de) Isoform des vegfs
PT1927597T (pt) Péptidos antibacterianos
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
DK1141014T3 (da) Insulinlignende vækstfaktor (IGF) i mutantvariant
DE60037800D1 (de) Stereoselektive antifibrillogene peptide
ATE321836T1 (de) Wässrige zusammensetzungen für oberflächebehandlung
ATE251448T1 (de) Polyol/öl-suspensionen zur verzörgerten freisetzung von proteinen
ATE491349T1 (de) Neue nutrazeutika-zusammensetzungen
AU2003231471A1 (en) Antimicrobial polypeptide and utizliation thereof
WO2001085781A3 (en) Repair of nerve damage
DE69839702D1 (de) Neue antimikrobielle polypeptide und verfahren für ihre verwendung.
GB0404374D0 (en) Treatment of bacterial infections
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
BR0213154A (pt) Compostos de glicopeptìdeo - cefalosporina de ligação reticulada, composições farmacêuticas de tais compostos, método de fabricação dos mesmos e seus usos
SE9503679D0 (sv) Antioxidants
DE60035270D1 (de) Previns als spezifische inhibitoren und therapeutika für botulinumtoxin b und tetanusneurotoxine
WO2001098327A3 (en) Glycopeptide carboxy-saccharide derivatives
MXPA05008080A (es) Inhibidores peptidicos de toxinas derivadas de la ll-37.
DE69615155T2 (de) Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
DK0801655T3 (da) Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika
ATE376557T1 (de) Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika
DE50213015D1 (de) Lipase-varianten
WO2002087554A3 (de) Ef-tu-bindende substanzen als ntibakterielles mittel